Molecular typing and antimicrobial susceptibility testing to six antimicrobials of Clostridium difficile isolates from three Czech hospitals in Eastern Bohemia in 2011-2012
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28332133
DOI
10.1007/s12223-017-0515-x
PII: 10.1007/s12223-017-0515-x
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální toxiny analýza genetika MeSH
- Clostridioides difficile klasifikace genetika izolace a purifikace MeSH
- diskové difúzní antimikrobiální testy MeSH
- incidence MeSH
- klostridiové infekce epidemiologie mikrobiologie MeSH
- lidé MeSH
- minisatelitní repetice MeSH
- molekulární typizace * MeSH
- nemocnice MeSH
- ribotypizace MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Názvy látek
- antibakteriální látky MeSH
- bakteriální toxiny MeSH
In 2011-2012, a survey was performed in three regional hospitals in the Czech Republic to determine the incidence of Clostridium difficile infections (CDIs) and to characterize bacterial isolates. C. difficile isolates were characterized by PCR ribotyping, toxin genes detection, multiple-locus variable-number tandem-repeat analysis (MLVA), and antimicrobial susceptibility testing to fidaxomicin, vancomycin, metronidazole, clindamycin, LFF571, and moxifloxacin using agar dilution method. The incidence of CDI in three studied hospitals was 145, 146, and 24 cases per 100,000 inhabitants in 2011 and 177, 258, and 67 cases per 100,000 inhabitants in 2012. A total of 64 isolates of C. difficile was available for molecular typing and antimicrobial susceptibility testing. 60.9% of the isolates were classified as ribotype 176. All 41 isolates of ribotypes 176 and 078 were positive for the presence of binary toxin genes. Ribotype 176 also carried 18-bp deletion in the regulatory gene tcdC. Tested isolates of C. difficile were fully susceptible to vancomycin and metronidazole, whereas 65.1% of the isolates were resistant to moxifloxacin. MLVA results indicated that isolates from three different hospitals were genetically related, suggesting transmission between healthcare facilities.
Department of Clinical Immunology and Microbiology Regional Hospital of Nachod Nachod Czech Republic
Department of Computer Science Faculty of Science University of Ostrava Ostrava Czech Republic
Department of Medical Microbiology Leiden University Medical Centre Leiden Netherlands
Zobrazit více v PubMed
Gut Liver. 2014 Jan;8(1):1-6 PubMed
Ann Clin Microbiol Antimicrob. 2015 Dec 23;14:55 PubMed
Mol Microbiol. 2007 Jun;64(5):1274-88 PubMed
Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1201-7 PubMed
Anaerobe. 2015 Feb;31:37-41 PubMed
Antimicrob Agents Chemother. 2000 Feb;44(2):411-3 PubMed
Folia Microbiol (Praha). 2014 Nov;59(6):523-6 PubMed
Nat Rev Microbiol. 2009 Jul;7(7):526-36 PubMed
J Clin Microbiol. 2002 Sep;40(9):3470-5 PubMed
J Clin Microbiol. 2007 Mar;45(3):1024-8 PubMed
Lancet. 2011 Apr 23;377(9775):1407 PubMed
Nat Microbiol. 2016 Jul 11;1(8):16108 PubMed
Anaerobe. 2009 Dec;15(6):237-40 PubMed
Clin Microbiol Infect. 2015 Mar;21(3):248.e9-248.e16 PubMed
J Med Microbiol. 2012 Jan;61(Pt 1):49-56 PubMed
J Clin Microbiol. 1999 Feb;37(2):461-3 PubMed
Clin Infect Dis. 2012 Oct;55(8):1056-63 PubMed
J Med Microbiol. 2008 Jun;57(Pt 6):702-8 PubMed
Clin Microbiol Infect. 2007 Nov;13(11):1058-64 PubMed
FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6 PubMed
Folia Microbiol (Praha). 2014 May;59(3):209-15 PubMed
Infection. 2007 Oct;35(5):300-7 PubMed
J Clin Microbiol. 2006 Jul;44(7):2558-66 PubMed
Anaerobe. 2015 Dec;36:88-90 PubMed
J Gastrointest Surg. 2013 Jan;17(1):118-24; discussion p.124-5 PubMed
Lancet. 2011 Jan 1;377(9759):63-73 PubMed
Antimicrob Agents Chemother. 2014 Jul;58(7):4214-8 PubMed
Anaerobe. 2014 Aug;28:13-7 PubMed
Dtsch Arztebl Int. 2014 Oct 24;111(43):723-31 PubMed
Clin Microbiol Infect. 2008 Nov;14(11):1057-64 PubMed
Clin Infect Dis. 2008 Nov 1;47(9):1162-70 PubMed
PLoS One. 2012;7(8):e43247 PubMed
J Antimicrob Chemother. 2015;70(6):1751-6 PubMed
J Antimicrob Chemother. 2013 Jun;68(6):1305-11 PubMed
Anaerobe. 2016 Dec;42:142-144 PubMed
PLoS One. 2015 Feb 13;10(2):e0118150 PubMed
Anaerobe. 2016 Aug;40:35-40 PubMed
